Charles P. Cooley
Analyst · J P Morgan. Please go ahead
Thank you, James. Good morning everyone. I will start my comments on the quarter with a few headlines and then I will get into the more detailed discussion. As James had said, Lubrizol sets quarterly record for consolidated revenues, sales revenues and as adjusted earnings, thanks to record performance in the Lubrizol Additive segment for revenue volume and operating income. As in the first quarter, the Additive segment delivered double-digit revenue growth in all international zones. The Lubrizol advanced material segments delivered significantly improved performance sequentially though some business areas do remain affected by weak demand in North America. In this quarter we continued to implement our coating improvement plan by announcing additional actions to consolidate North American manufacturing capacity. And lastly, both segments under took timely and significant price actions in the quarter to address the significantly higher raw material and operating costs. If you are following along with the PowerPoint presentation on our website and investor relations release page, I am now on page four, where you can see the consolidated earnings for second quarter of 2008 compared with the year ago period. As a reminder, all references to earnings per share will be on a diluted basis. Yesterday, we announced at that consolidated earnings for the second quarter of 2008 were $78.1 million or $1.13 per share including restructuring and impairment charges of $0.13 per share primarily related to the business improvement initiatives and North American manufacturing consolidation in our performance coatings product line. Consolidated earnings for the second quarter of 2007 were $81 million or $1.15 per share and included a restructuring and impairment charge of $0.01 per share primarily related to the impairment of an investment in one of the advanced material product lines. So, when we exclude the restructuring and impairment charges in both years, adjusted earnings or $1.26 per share for the quarter, were 9% higher than the second quarter 2007. The primary drivers of the consolidated earnings growth were improvement and a combination of price and product mix, higher volumes, favorable currency and contributions from acquisitions. These positive factors to earnings more than offset the impact of higher raw material costs, higher manufacturing costs and an increase in the effected tax rate. Turning to slide five, consolidated revenues increased 17% from the second quarter 2007 to $1.35 billions. Compared with the year ago period, improvements in the combination of price and product mix increased revenues by 8%, volume increased 5% and currency had a 4% favorable impact to revenues. Included in these factors was the incremental impact from last year's Refrigeration Lubricant acquisition which contributed 2% to consolidated revenues in the quarter. Gross profit rose 3% in the quarter, as the higher revenues more than offset higher raw material and manufacturing costs. Continuing the pattern we've seen over the last several years, gross profit dollars increased year-over-year even though gross profit percentage declined 300 basis points, because the rate of increases in revenue due to pricing has out paced the rate of increase in gross profit dollars. If you look at the gross profit performance since 2005, this phenomenon is quite dramatic. Lubrizol's first half gross profits has grown over $120 million, representing a compound annual growth rate of 8% since the first half of 2005, yet over that period gross profits percentage has declined 340 basis points. This mainly reflects Lubrizol Additive success in recovering the extraordinary rise in raw material costs over this timeframe. STAR expenses were leveled with the second quarter of 2007. Research and testing expenses of $56 million in the quarter were up 4% largely due to increased outside testing expenses with the remainder of the increase primarily attributable to unfavorable currency. Selling and administrative expenses of $102 million were down 1% due to favorable swing related to the mark-to-market affects of our stock based incentive compensation plan for international participants. This decline partially was offset by unfavorable currency effects and incremental SAP project costs. Over the last several years we have been providing our estimates of the impact of currency fluctuations on the bottom-line. Currency provided $0.01 EPS benefit in the quarter relative to what we were expecting at the time of our May guidance. Compared to the second quarter of 2007, we estimate the impact of currency to be a favorable $0.16 per share. But I want to know note that in the current environment of dramatically increasing material costs, the impact of currency cannot be viewed in isolation, because our pricing actions take currency change into account. For example its fair to say that had the dollar fallen less relative to the Euro recently, we likely would have pushed forth and achieved greater price increases in Europe. Adjust EBIT which excludes restructuring and impairment charges and credits rose 8% in the quarter to $142 million. Net interest expense was comparable to the year ago quarter at $17.6 million. Turning to taxes, earnings as adjusted for restructuring and impairment charges were taxed as an effective rate of 29.1% in the quarter as compared with 28.3% in the last quarter second quarter. As you may recall, last years rate benefited from the resolution of some tax matters from prior years. The 29.1% tax rate for the current quarter is lower than stated in our previous guidance, largely as a result of the tax favorable improvement in geographic earnings mix. And now I will turn to segment results which are shown starting on slide six. Revenue for the Lubrizol Additive segment in the quarter were 22% year-over-year, a 9% higher volume. The combination of price and product mix improved revenues 8% and the currency contributed 5%. Volumes surpassed the quarterly record established in the first quarter of this year and was particularly strong outside of North America. Latin America volumes increased 30%. Asia-Pacific was up 26% and Europe was up 9% while North America volumes declined 6%. The Refrigeration Lubricant acquisition completed in late 2007 contributed one-fourth of the volume growth in the quarter. We attribute the outstanding volume growth in our International regions to three factors. First we are very well positioned in the fastest growing market. Second, we have a solid technology position and extensive supply-chain that customer's value. And third, we are well-positioned with the customers that are winning in the marketplace. In North America, we attribute two percentage points of the decline to a general demand weakness and the remainder to changes in customer order pattern and sales of more highly concentrated products. Lubrizol Additives has announced four price increases since landfall. The most recent increase was announced July 3rd. The magnitude of our price increases has grown as the rate of raw material cost increases have grown. Furthermore, we have shortened even further the time lag between raw material cost increase and selling price increase implementation. To boil it all down, we project the current round of price increases will bring us up to unit material margin levels that is material margin dollars per unit of product sold that exceed the levels we saw in mid 2007, a period that preceded the recent rapid run-up in material costs. Unit material margin is our primary metric for price measuring price increase success. Segment operating income in the quarter increased 10%, primarily as a result of the improvement and combination of the price and product mix. Higher volume, favorable currency and the contribution from the refrigeration lubricants acquisition, which all combined more than offset the impacts of higher raw materials and manufacturing costs. Excluding the contribution from the acquisition, operating income increased 7%. Before I move to the Advanced Materials segment, I want to note that this past Tuesday we announced plans to close our Lubrizol Additives blending facility in Canada. We expect to record restructuring charges associated with the closure of $0.06 per share in the second half, with additional charges expected in 2009 and 2010 totaling approximately $0.06 per share. Annual savings from this closure which will be completed by mid-2009 are projected to be $4 million. Turning to the Lubrizol Advanced Materials segment on slide seven, second quarter revenues were up 8% over last year. The increase reflected a 7% favorable impact from the combination of price and product mix, a 4% favorable currency impact and the 3% decline in volume. The increase in the combination of price and product mix reflects pricing actions across all product lines in the segment. And to that point, unit material margins in this segment were 2% higher in the quarter versus the comparable quarter last year. The decrease in volume primarily was due to general weakness in our North American Performance Coatings product line. This decrease partially was offset by very strong overall volume growth in Asia-Pacific/Middle East with Performance Coatings, TempRite Engineered Polymers And Noveon Consumer Specialties all growing over 20% and Estane Engineered Polymers volumes up 9%. Europe volumes declined 7% from the second quarter of last year due to weakness across our Performance Coatings product line. The Performance Coatings product line also shed some low margin business as part of its restructuring initiatives. I will now go into the Advanced Materials product lines in a little more detail. Noveon Consumer Specialties product line had record revenues of $119 million, up 14% from the second quarter of 2007 on record volume. We saw a rebound globally in our powdered Carbopol volume which was up 10% both sequentially and versus the prior year. Our new liquid Carbopol product continued their excellent performance with 27% higher volume. And we continued to see good growth in the surfactants business due to strong demand at key customers. Revenues in the Performance Coatings product line were $141 million in the quarter which were level with the second quarter of 2007. As noted earlier, this product line continues to be impacted by the weakness in the North American and European textiles and coatings industries. We saw very strong volume growth of 28% in Asia-Pacific. China was a major contributor to this growth. We've seen strong performance there and expect this to continue with the completion of our new production facility which will be on line in early 2009. The coatings team took further steps in its business improvement plan. During the quarter, we recorded a restructuring and impairment charge of $0.13 per share, related to the commercial reorganization that we discussed during last quarter's teleconference and the closure of two manufacturing units. The actions that we have announced to date are expected to generate cost savings of approximately $3 million in 2008 and over$7 million in 2009. The team also is continuing to evaluate other steps this year that could produce additional benefits. The Engineered Polymers product line, consisting of TempRite and Estane engineered polymers reported revenues of $167 million in the quarter, up 11% from the second quarter of 2007. Estane revenues increased 15% from the second quarter of 2007, as we had double-digit volume growth in North America and strong pricing and product mix impact across the entire platform. Demand and North American film and sheet and hose and tube applications remain strong TempRite revenues were up 7% due to record volumes in the commercial water and industrial products as well as increased demand in international regions. All international regions saw double-digit increases. North American volume was down 8% due to a continued decline in residential plumbing volumes and weakness in the fire sprinkler market, that partially were offset by higher sales of commercial and industrial products. Profitability in our TempRite business is continued to be challenged due to material cost increases. In April and July, we announced significant price increases in all regions to offset the steep runoff in material cost. To summarize, Lubrizol Advanced Materials segment operating income in the quarter decreased 15% from the second quarter of 2007. Excellent earnings performance by the consumer specialties and Estane businesses were more than offset by the impact of weak North American coatings and construction markets on our Performance Coatings and TempRite businesses. However, we believe that our pricing and business improvement initiatives are gaining traction. We forecast the second half to show solid improvement over 2007 second half results. On June 2nd, we went live with our North American SAP implementation in Advanced Materials. As noted in previous teleconferences, Advanced Materials' operating results reflect the higher level of spending associated with this project. The second quarter results included $5 million in incremental IT expenses versus the second quarter of last year, mostly related to SAP implementation. And for 2008, we are anticipating a $10 million increase over full year 2007. We expect this level of IT spending to abate once SAP has been rolled out globally. We also have been investing in commercial, technical and manufacturing resources, especially in Asia to support our growth plans. For the full year, we estimate incremental growth spending to be $5 million compared with 2007. So, our investments and information technology and growth resources, which we believe are critical to the future success, are adding about $15 million in expense in the current year. I will now comment on several other financial items noted on slide eight. Corporate expenses were $13 million in the second quarter of 2008, down significantly from the second quarter of 2007 partly due to the favorable swing in earnings related to the mark-to-market effects of the stock based incentive compensation plan for international participants. We generated $96 million in cash flow from operations in the first half of 2008, down from $227 million in the same period of 2007. This decrease in operating cash flow compared to last year was driven by the significant inventory reductions we under are took last year in combination with a build in working capital this year. Our management of working capital continues to be excellent. Inventory days improved compared with 2007 while days sales outstanding increased slightly as a result of geographic sales mix. But this year's strong revenues and higher inventory costs drive by the extraordinary increase in raw material cost are the major factors behind the $159 million increase in the value of our networking capital since December 31st. Regarding our uses of cash in the quarter, capital expenditures were $46 million. We were repurchased 451,000 common shares for $25 million and we paid up dividends of slightly over $21 million. As the result of these activities our cash balance at June 30th was $420 million compared with $502 million at December 31, 2007. We currently anticipate using some of this cash in December to retire $200 million in notes. For the 12 months ending June 30, 2008. Return on invested capital improved to 11.5% compared with 11% for the comparable period in 2007. And now, I will turn to the outlook on slides nine and ten. Our outlook is premised on and expectation of continued economic softness in North America as well as in some of our European ends use markets. But in view of our strong first half results and our projection for the balance of the year, we are updating our guidance. Our updated guidance is $4.20 to $4.35 per share including $0.23 per share for restructuring and impairment charges. The last page the teleconference presentation provides an outline of these charges which relate to the improvement initiatives in our Performance Coatings product lines that I described earlier and the plant closure of the Canadian additives blending operation. Our increased guidance for adjusted earnings excluding restructuring and impairment charges is in the range of $4.43 to $4.58 per share which is a 9% to 13% increase in adjusted earnings compared with 2007 results. And here are the updates to our key assumptions. Consolidated revenue growth of approximately 18% to 19% and consolidated adjusted EBIT growth to 11.5% to 12% compared with 2007. For Lubrizol Additives, excluding acquisitions we are raising our volume growth assumption to 3%. For Lubrizol Advanced Material, we now project volumes contraction of approximately 3% due to North American demand weakness and Performance Coatings restructuring activity. We are modeling unit material margin in both segments to improve steadily during the remainder of the year as price increases offset higher second half raw material cost. We are modeling STAR expense to be approximately 12.5% of revenues and we revised downward our effective tax rate assumption for the year to 31% largely as the result of a tax favorable improvement in geographic earnings mix. And finally we are modeling the Euro to average $1.55 is the reminder of the year. The key updates to our cash flow outlook are shown in slide 11 and are these. Capital spending is now projected to be $220 and $230 million down slightly from an earlier guidance. We are now assuming a working capital build in excess of $200 million due to higher inventory values and selling prices as well as our plans to maintain security of supply for our customers. Though not a change, we continue to target share repurchases of $100 million for the full year. I would like to conclude by saying that despite the great challenges and uncertainties out there we are pleased with our operating and financial performance this year. Our overall fundamentals remain strong and we feel we are well positioned into the second half and in fact July has been another strong revenue month for us. And with that I now open it up for Q&A. Kevin? Question And Answer